NCT05313100View on ClinicalTrials.gov

Sugammadex and Smoker's Neuromuscular Block

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

August 31, 2013

Conditions
Neuromuscular BlockadeSmoking
Interventions
DRUG

sugammadex

At the end of the operation, at least 15 minutes after the last dose of rocuronium, sugammadex 2 mg / kg was administered both of groups

All Listed Sponsors
lead

Duzce University

OTHER

NCT05313100 - Sugammadex and Smoker's Neuromuscular Block | Biotech Hunter | Biotech Hunter